Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > 13 July 2022 15$ US target maintained

View:

Post by askretka on Jul 15, 2022 6:55pm

13 July 2022 15$ US target maintained

In a report released today,Patrick Trucchiofrom H.C. Wainwright maintained aBuyrating on Oncolytics Biotech (ONCYResearch Report), with a price target of$15.00. The companys shares closed last Thursday at $0.98, close to its 52-week low of $0.80.

323

Comment

Comment by cardu on Jul 17, 2022 11:00am

$20 cad i'd be satisfied. $25 I'd be happy. $30 i'd be exstatic. $40 i'd be a millionaire.

199

Comment

Comment by fox7mf on Jul 17, 2022 11:42am

$40 I'd be satisfied. $80 I'd be happy. $100 I'd be ecstatic....

197

Comment

Comment by canadafan on Jul 17, 2022 7:49pm

My satisfied, happy, ecstatic? don't really know? The $15ps target includes very little extra developments. Only assumes a phase 3 partnership. a total buy out, interesting has never been discussed by any analysts. The present math indicates roughly $15ps/ billion of company value. It was mentioned on another site, that the tax loss value for an acquiring company is in excess of $5ps. Meaning ...more

248

Comment